93 related articles for article (PubMed ID: 11286810)
1. Expression of phosphodiesterase 3 in rat submandibular gland cell lines.
Murata T; Sugatani T; Manganiello VC; Shimizu K; Tagawa T
Arch Oral Biol; 2001 May; 46(5):453-7. PubMed ID: 11286810
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphodiesterase 3 in rat submandibular gland.
Murata T; Sugatani T; Tagawa T
Arch Oral Biol; 2000 Dec; 45(12):1043-7. PubMed ID: 11084143
[TBL] [Abstract][Full Text] [Related]
3. Expression of cyclic nucleotide phosphodiesterase 3A in isolated rat submandibular acini.
Shimizu K; Murata T; Hiramoto K; Sugiyama T; Nakagawa T; Manganiello VC; Tagawa T
Arch Oral Biol; 2006 Feb; 51(2):83-8. PubMed ID: 16102722
[TBL] [Abstract][Full Text] [Related]
4. Changes in phosphodiesterase activity in the developing rat submandibular gland.
Tanaka S; Shimooka S; Shimomura H
Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 3 as a potential target for therapy of malignant tumors in the submandibular gland.
Murata T; Sugatani T; Shimizu K; Manganiello VC; Tagawa T
Anticancer Drugs; 2001 Jan; 12(1):79-83. PubMed ID: 11272291
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
Liu H; Maurice DH
Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
9. Expression and role of phosphodiesterase 3 in human squamous cell carcinoma KB cells.
Shimizu K; Murata T; Okumura K; Manganiello VC; Tagawa T
Anticancer Drugs; 2002 Sep; 13(8):875-80. PubMed ID: 12394274
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of phosphodiesterase 2A in the submandibular gland of mice.
Adthapanyawanich K; Nakata H; Iseki S
Arch Oral Biol; 2018 Jun; 90():91-99. PubMed ID: 29597062
[TBL] [Abstract][Full Text] [Related]
11. Differential cellular pattern of gene expression for two distinct cGMP-inhibited cyclic nucleotide phosphodiesterases in developing and mature rat brain.
Reinhardt RR; Bondy CA
Neuroscience; 1996 May; 72(2):567-78. PubMed ID: 8737425
[TBL] [Abstract][Full Text] [Related]
12. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
Murray F; MacLean MR; Pyne NJ
Br J Pharmacol; 2002 Dec; 137(8):1187-94. PubMed ID: 12466227
[TBL] [Abstract][Full Text] [Related]
14. Dual expression and differential regulation of phosphodiesterase 3A and phosphodiesterase 3B in human vascular smooth muscle: implications for phosphodiesterase 3 inhibition in human cardiovascular tissues.
Palmer D; Maurice DH
Mol Pharmacol; 2000 Aug; 58(2):247-52. PubMed ID: 10908291
[TBL] [Abstract][Full Text] [Related]
15. Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells.
Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Zhou W; Grande JP
Exp Biol Med (Maywood); 2006 Mar; 231(3):288-95. PubMed ID: 16514175
[TBL] [Abstract][Full Text] [Related]
16. Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant.
Erdogan S; Houslay MD
Biochem J; 1997 Jan; 321 ( Pt 1)(Pt 1):165-75. PubMed ID: 9003416
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3).
He R; Komas N; Ekholm D; Murata T; Taira M; Hockman S; Degerman E; Manganiello VC
Cell Biochem Biophys; 1998; 29(1-2):89-111. PubMed ID: 9631240
[TBL] [Abstract][Full Text] [Related]
18. Characterization of phosphodiesterase 3 in human malignant melanoma cell line.
Murata T; Shimizu K; Narita M; Manganiello VC; Tagawa T
Anticancer Res; 2002; 22(6A):3171-4. PubMed ID: 12530061
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of cyclic nucleotide phosphodiesterase 3 and 4 activities in human T cell clones specific for myelin basic protein.
Ekholm D; Hemmer B; Gao G; Vergelli M; Martin R; Manganiello V
J Immunol; 1997 Aug; 159(3):1520-9. PubMed ID: 9233651
[TBL] [Abstract][Full Text] [Related]
20. Vascular smooth muscle cell phosphodiesterase (PDE) 3 and PDE4 activities and levels are regulated by cyclic AMP in vivo.
Tilley DG; Maurice DH
Mol Pharmacol; 2002 Sep; 62(3):497-506. PubMed ID: 12181425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
